Clinical Trials Logo

Clinical Trial Summary

For the majority of Coronary Artery Disease (CAD) treatment with Percutaneous Transluminal Coronary Angioplasty (PTCA) provides high initial procedure success. However, the medium to long-term complications range from rather immediate elastic coil or vessel contraction to longer processes like smooth muscle cell proliferation and excessive production of extra cellular matrix, thrombus formation and atherosclerotic changes like restenosis or angiographic re-narrowing. The reported incidence of restenosis after PTCA ranges from 30 to 50%. Such rates of recurrence have serious economic consequences. Bare Metal Stents (BMS), designed to address the limitations of PTCA, reduced the angiographic and clinical restenosis rates in De Novo lesions compared to PTCA alone and decreased the need for CABG. BMS substantially reduced the incidence of abrupt artery closure, but restenosis still occurred in about 20 to 40% of cases, necessitating repeat procedures.

The invention of Drug Eluting Stents (DES) significantly improved on the principle of BMS by adding an antiproliferative drug (directly immobilized on the stent surface or released from a polymer matrix), which inhibits neointimal hyperplasia. The introduction of DES greatly reduced the incidence of restenosis and resulted in better safety profile as compared to BMS with systemic drug administration. These advantages and a lower cost compared to surgical interventions has made DES an attractive option to treat coronary artery disease.

Therefore this observational registry has been designed for the clinical evaluation of the ORSIRO LESS requiring coronary revascularization with DES. It is designed to investigate and collect clinical evidence for the clinical performance and safety of the Orsiro Drug Eluting Stent System in an all-comers patient population in daily clinical practice.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02273648
Study type Observational
Source Biotronik France
Contact
Status Active, not recruiting
Phase N/A
Start date November 19, 2014
Completion date September 2021

See also
  Status Clinical Trial Phase
Completed NCT00328315 - Cardiac SPECT With Rotating Slant Hole Collimator
Recruiting NCT02257710 - BIOFLOW-III UK Satellite Registry Orsiro Stent System N/A
Recruiting NCT01157455 - A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Phase 4
Completed NCT02028728 - BIOFLOW III Satellite-Italy Orsiro Stent System N/A
Completed NCT02813473 - SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease
Completed NCT05853250 - Clinical and Hospital Stay Effects of Reiki and Manual Therapy After Open Heart Surgery N/A
Recruiting NCT02635230 - What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Completed NCT01116882 - Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings N/A
Completed NCT00920283 - COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilmâ„¢ Coated Stent N/A
Completed NCT01700075 - Physical and Chemical Study of Atherosclerosis Mechanisms Phase 4
Completed NCT00607178 - The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases Phase 2/Phase 3
Completed NCT00607217 - The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases Phase 2/Phase 3
Not yet recruiting NCT05486780 - The Effect of Digital Window on Day and Night Perception Status and Sleep Quality in Intensive Care Patients N/A
Terminated NCT01665248 - Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina N/A
Terminated NCT01612819 - DXR Stent(Previous Cilotax) Implantation Registry N/A
Active, not recruiting NCT01226355 - NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System N/A
Recruiting NCT02247492 - BIOFLOW-III VIP Russia Registry Orsiro Stent System